Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines - Pfizer

As reported by Pfizer.com

Pfizer Inc. (NYSE: PFE) and Innovent Biologics, Inc. (01801.HK), today announced the companies have entered into a strategic global licensing and collaboration agreement for the research and development of 12 promising new breakthrough early-stage and de novo…

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Pfizer.com ↗

Market Samachar is a news aggregator. This article was originally published by Pfizer.com. Tap the button above to read the full story on their site.

INDIAN Claude-maker Anthropic halves list of unauthorised share trading platforms after investor concerns: Which firms remain? mint - markets
CRYPTO SEC charges Texas man with $12.3M crypto fraud using fake AI trading bots Cointelegraph.com News
CRYPTO Florida Candidate Liquidates $800K in Bitcoin to Bankroll Congressional Bid Decrypt
GLOBAL DOJ seeks Judge Eleanor Ross recusal in Georgia election case, citing reports she was disciplined CNBC
GLOBAL Net worth matters more than income when it comes to financial anxiety, survey finds CNBC
GLOBAL IMF, World Bank, others warn Middle East war is straining energy supplies - Reuters Reuters
CRYPTO SEC sues Texas man over $12.3 million alleged crypto scheme built on fake AI trading bots CoinDesk: Bitcoin, Ethereum, Crypto News and Price Data
CRYPTO U.S. says it seized about $1 billion in Iranian crypto as pressure campaign expands CoinDesk: Bitcoin, Ethereum, Crypto News and Price Data

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines - Pfizer

More from Market Samachar